Abstract
BackgroundThe development of biological medicines (BM) was a major step in the treatment of chronic diseases and cancer. However, their high costs are a financial issue for hospitals. The arrival...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Hospital Pharmacy: Science and Practice
Paper Title
Journal
Date
